Atara Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 08/14/2026 | 1.55 M | $17.82 M | 1,458.34% | 11.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 850.00 K | $9.76 M | 21.43% | 6.04% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 687.72 K | $7.90 M | 254.01% | 4.88% |
| REDMILE GROUP, LLC | 08/14/2026 | 441.70 K | $5.07 M | 0.00% | 3.14% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 247.05 K | $2.84 M | 13.40% | 1.75% |
| MACKENZIE FINANCIAL CORP | 08/13/2026 | 233.25 K | $2.68 M | -25.63% | 1.66% |
| BLACKROCK, INC. | 08/07/2026 | 84.46 K | $969.54 K | 6.88% | 0.60% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 75.13 K | $862.92 K | 13.58% | 0.53% |
| STALEY CAPITAL ADVISERS INC | 08/11/2026 | 50.00 K | $574.00 K | 0.00% | 0.36% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 43.04 K | $494.05 K | 28.00% | 0.31% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 38.85 K | $444.00 K | -70.33% | 0.28% |
| JANE STREET GROUP, LLC | 08/14/2026 | 30.35 K | $348.36 K | -10.41% | 0.22% |
| STATE STREET CORP | 08/07/2026 | 26.45 K | $303.68 K | 0.00% | 0.19% |
| NORTHERN TRUST CORP | 08/13/2026 | 16.59 K | $190.47 K | 34.45% | 0.12% |
| FMR LLC | 08/13/2026 | 16.24 K | $186.41 K | 0.00% | 0.12% |
| XTX TOPCO LTD | 08/14/2026 | 15.30 K | $175.68 K | 100.00% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 14.00 K | $160.72 K | -57.17% | 0.10% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 12.68 K | $145.57 K | -73.41% | 0.09% |
| CITADEL ADVISORS LLC | 08/14/2026 | 10.16 K | $116.63 K | 100.00% | 0.07% |
| MORGAN STANLEY | 08/13/2026 | 9.18 K | $105.37 K | 0.10% | 0.07% |
| ROYAL BANK OF CANADA | 08/14/2026 | 4.74 K | $55.00 K | 9.82% | 0.03% |
| UBS GROUP AG | 08/13/2026 | 3.98 K | $45.68 K | -92.05% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 1.46 K | $16.72 K | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 1.40 K | $16.12 K | -10.80% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 803 | $8.44 K | 14.22% | 0.01% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 311 | $3.57 K | 100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 304 | $3.49 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 251 | $2.88 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 216 | $2.41 K | 0.00% | 0.00% |
| RAIFFEISEN BANK INTERNATIONAL AG | 08/03/2026 | 200 | $2.30 K | 0.00% | 0.00% |
| BANQUE TRANSATLANTIQUE SA | 07/30/2026 | 176 | $3.10 K | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 97 | $1.11 K | 9,600.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 46 | $528 | -20.69% | 0.00% |
| KERR FINANCIAL PLANNING CORP | 07/02/2026 | 24 | $276 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 10 | $114 | 0.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 8 | $92 | 0.00% | 0.00% |
| RHUMBLINE ADVISERS | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WESTERN WEALTH MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Atara Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 74 institutional investors and hedge funds held shares of Atara Biotherapeutics Inc. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 1.55 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 850,000
Point72 Asset Management, L.P.: 687,718
Redmile Group, LLC: 441,701
VANGUARD CAPITAL MANAGEMENT LLC: 247,047
MACKENZIE FINANCIAL CORP: 233,249
31.73% of Atara Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 9.81 M shares in the last 24 months. This purchase volume represents approximately $65.52 M in transactions.